ATOPIC ECZEMA

Clinical trials for ATOPIC ECZEMA explained in plain language.

Never miss a new study

Get alerted when new ATOPIC ECZEMA trials appear

Sign up with your email to follow new studies for ATOPIC ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 3 Not yet finished but already full! 2 Completed 1

Eczema drug dupilumab shows promise in skin of color patients

Disease control Completed

This study tested the drug dupilumab (Dupixent) in 124 adolescents and adults with darker skin tones who have moderate-to-severe eczema. Participants received injections every two weeks for 24 weeks. The goal was to see if the drug safely improves skin symptoms and quality of lif…

Matched conditions: ATOPIC ECZEMA

Phase: PHASE4 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

ATOPIC ECZEMA

Get alerted when new ATOPIC ECZEMA trials appear

Eczema drug dupilumab shows promise in skin of color patients